Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Saturday, December 10, 2022 · 605,551,072 Articles · 3+ Million Readers

With 14.7% CAGR, Cancer Vaccines Market Size to Hit USD 19.12 Billion in 2029

According to Fortune Business Insights, The global cancer vaccines market size was valued at USD 6.43 billion in 2021. The market is expected to grow from USD 7.32 billion in 2022 to USD 19.12 billion by 2029, exhibiting a CAGR of 14.7% during the forecast period

/EIN News/ -- Pune, India, Nov. 21, 2022 (GLOBE NEWSWIRE) -- The global cancer vaccines market size was valued at USD 6.43 billion in 2021. The market is expected to grow from USD 7.32 billion in 2022 to USD 19.12 billion by 2029, exhibiting a CAGR of 14.7% during the forecast period. The market is expected to exhibit a CAGR of 14.7% during the forecast period. Increasing cancer cases and strong investments in prophylactic and preventive vaccines may propel market progress. Fortune Business Insights™ provides this information in its report titled “Cancer Vaccines Market, 2022-2029.”


Request Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/sample/cancer-vaccines-market-106958


Cancer Vaccines Market Report Scope & Segmentation:

Report Coverage Details
Forecast Period 2022 to 2029
Forecast Period 2022 to 2029 CAGR 14.7%
2029 Value Projection USD 19.12 Billion
Base Year 2021
Market Size in 2021 USD 6.43 Billion
Historical Data for 2018 to 2020
No. of Pages 136


COVID-19 Impact:

Manufacturing Restraints Hindered Industry Growth During the Pandemic

This industry was negatively affected during the COVID-19 pandemic, attributable to manufacturing restrictions. The sudden spike in COVID-19 infections provoked governments to impose strict restrictions on manufacturing, thereby affecting cancer vaccines’ production. Further, travel and transport restrictions hindered the availability of raw materials required to produce vaccines. However, the adoption of part-time shifts, reduced capacities, and industrial automation allowed companies to balance their costs during the pandemic.

Segments

Preventive Segment to Dominate Backed by Increasing Initiatives of Mass Immunization by Government Agencies

By type, the market is segmented into preventive and therapeutic. The preventive segment is expected to dominate due to rising initiatives of mass immunization by government agencies.

Cervical Cancer Segment to Lead Attributable to Increasing Number of Cervical Cancer Cases in Women

As per indication, the market is segregated into cervical cancer, bladder cancer, prostate cancer, and lung cancer. The cervical cancer segment is expected to dominate due to the rising number of cervical cases among women.

Hospitals Segment to Lead Due to Rising Outpatient Visits and Easy Availability of Vaccines in Hospitals

Based on distributional channel, the market is classified into hospitals, government suppliers, and others. The hospitals segment is expected to lead due to rising outpatient visits and easy availability of vaccines in hospitals.

Regionally, the market is grouped into North America, Europe, Asia Pacific, and the Rest of the World.


Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/cancer-vaccines-market-106958


Drivers and Restraints

Rising Collaborations Among Major Players to Foster Market Progress

Cancer vaccines cure several cancers and are likely to gain significant demand due to the increasing prevalence of cancer cases. Increasing collaborations among key players may substantially boost vaccine adoption during the forecast period. For example, UbiVac, Inc. declared a collaboration alongside Bristol Myers Squibb in June 2020 to evaluate preliminary efficacy, tolerability, and safety among patients. Furthermore, increasing pollution, sedentary lifestyles, and alcohol consumption may enhance cancer vaccine demand. Moreover, the rising prevalence of cervical cancer cases among women may drive the cancer vaccines market growth.

However, personalized medicine advances will likely limit the industry’s growth.

Regional Insights

Presence of Technologically Developed Healthcare Infrastructure to Foster Market Growth in North America

The market in North America stood at USD 2.45 billion in 2021 and is expected to gain a huge portion of the global cancer vaccines market share in the coming years. The presence of several technologically developed healthcare facilities is likely to facilitate industry growth. Furthermore, rising cancer cases globally are expected to enhance the product demand.

In Europe, rising cancer vaccines’ research and development investments are expected to foster the industry’s progress. Furthermore, rapidly increasing cancer disorders are expected to enhance the adoption of cancer vaccines.

In Asia Pacific, increasing government activities to prevent cancer disorders is expected to enhance the demand for the product. Moreover, the increasing adoption of cancer therapeutics is expected to enhance the region's cancer vaccine industry’s progress.


Quick Buy - Cancer Vaccines Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/106958


Competitive Landscape

Key Players Announce Novel Products to Boost their Brand Image

The prominent companies operating in the market announce new products to boost their brand image. For example, Dendreon Pharmaceuticals LLC. announced its manufacturing and CMC alliance to transform iSPC cellular technology in November 2021. This strategy may enable the company to improve its brand image and increase sales. Further, companies deploy research and development, mergers, partnerships, acquisitions, and innovations to boost their market position.

Key Industry Development

  • November 2021: Dendreon Pharmaceuticals LLC. entered into a partnership with Grant Hill to launch its novel initiative to empower individuals to make effective decisions to tackle prostate cancer.

List of Key Players Profiled in the Report

  • Merck & Co., Inc. (U.S.)
  • GSK plc (U.K.)
  • Dendreon Pharmaceuticals LLC. (U.S.)
  • Walvax Biotechnology Co., Ltd. (China)
  • Biomed Lublin S.A. (Poland)
  • Serum Institute of India Pvt. Ltd. (India)
  • Center of Molecular Immunology (Cuba)
  • Organon Teknika Corp., LLC (U.S.)
  • Xiamen Innovax Biotech Co., Ltd. (China)


Speak To Our Analyst: 

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cancer-vaccines-market-106958


Table Of Contents :

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Market Trends
  • Key Insights
    • Prevalence of Cancer, Key Countries/ Region, 2021
    • Overview of Regulatory Scenario by Key Countries
    • Pipeline Analysis, Key Players
    • Key Industry Developments, Mergers, Acquisitions, Product Launches, etc.
    • Impact of COVID-19 on Global Cancer Vaccines Market
  • Global Cancer Vaccines Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Type
      •  Preventive
      •  Therapeutic
    • Market Analysis, Insights and Forecast – By Indication
    • Market Analysis, Insights and Forecast – By Distribution Channel
      •   Hospitals
      •   Government Suppliers
      •   Others
      •   Cervical Cancer
      •   Prostate Cancer
      •   Bladder Cancer
      •   Lung Cancer
    • Market Analysis, Insights and Forecast – By Region
      •  North America
      •  Europe
      •  Asia Pacific
      •  Rest of the World
  • North America Cancer Vaccines Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Type
      •   Preventive
      •   Therapeutic
    • Market Analysis, Insights and Forecast – By Indication
    • Market Analysis, Insights and Forecast – By Distribution Channel
      •   Hospitals
      •   Government Suppliers
      •   Others
      •   Cervical Cancer
      •   Prostate Cancer
      •   Bladder Cancer
      •   Lung Cancer
    • Market Analysis, Insights and Forecast – By Country
      •   U.S.
      •   Canada
  • Europe Cancer Vaccines Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Type
      •  Preventive
      •  Therapeutic
    • Market Analysis, Insights and Forecast – By Indication
    • Market Analysis, Insights and Forecast – By Distribution Channel
      •   Hospitals
      •   Government Suppliers
      •   Others
      •   Cervical Cancer
      •   Prostate Cancer
      •   Bladder Cancer
      •   Lung Cancer
    • Market Analysis, Insights and Forecast – By Country/Sub-region
      •   France
      •   Italy
      •   Spain
      •   UK
      •   Germany
      •   Rest of Europe
  • Asia Pacific Cancer Vaccines Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Type
      •  Preventive
      •  Therapeutic
    • Market Analysis, Insights and Forecast – By Indication
    • Market Analysis, Insights and Forecast – By Distribution Channel
      •   Hospitals
      •   Government Suppliers
      •   Others
      •   Cervical Cancer
      •   Prostate Cancer
      •   Bladder Cancer
      •   Lung Cancer
    • Market Analysis, Insights and Forecast – By Country/Sub-region
      •  India
      •  China
      •  Australia
      •  Japan
      •  Southeast Asia
      •  Rest of Asia Pacific

Toc Continue…


Ask for Customization of this Report:

https://www.fortunebusinessinsights.com/enquiry/customization/cancer-vaccines-market-106958


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com


Primary Logo

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release